Open Access
Volume 21, Number 3, May-June 2014
Article Number D304
Number of page(s) 12
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
Published online 29 April 2014
  • Adami S, Giannini S, Bianchi L, et al. 2009. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos. Int. 20: 239–244. [Google Scholar]
  • Adams J, Hewison M. 2010. Update in vitamin D. J. Clin. Endocrinol. Metab. 95: 471–478. [Google Scholar]
  • Aloia J, Talwar S, Pollack S, et al. 2006. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am. J. Clin. Nutr. 84: 602–609. [Google Scholar]
  • Armas LAG, Hollis BW, Heaney RP. 2004. Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab. 89: 5387–5391. [CrossRef] [PubMed] [Google Scholar]
  • Arnson Y, Amital H, Shoenfeld Y. 2007. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis. 66: 1137–1142. [Google Scholar]
  • Autier P, Gandini S. 2007. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167: 1730–1737. [Google Scholar]
  • Benhamou CL, Souberbielle JC, Cortet B, et al. 2011. La vitamine D chez l’adulte: recommandations du GRIO. La presse médicale, 7–16. [Google Scholar]
  • Bienaime F, Girard D, Anglicheau D, et al. 2013. Vitamin D, renal function and outcome in renal transplantation. J. Am. Soc. Nephrol. 24: 831-841. [Google Scholar]
  • Bischoff-Ferrari H, Dawson-Hughes B, Staehelin HB, et al. 2009a. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339: b3692. [Google Scholar]
  • Bischoff-Ferrari H, Dietrich T, Orav EJ, et al. 2004. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am. J. Med. 116: 634–639. [CrossRef] [PubMed] [Google Scholar]
  • Bischoff-Ferrari H, Giovanucci E, Willett W, et al. 2006. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple outcomes. Am. J. Clin. Nutr. 84: 18. [Google Scholar]
  • Bischoff-Ferrari H, Willett W, Orav E, et al. 2012. A pooled analysis of vitamin D dose requirements for fracture prevention. N. Engl. J. Med. 367: 40–49. [CrossRef] [PubMed] [Google Scholar]
  • Bischoff-Ferrari H, Willett W, Wong J, et al. 2009b. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch. Int. Med. 169: 551–561. [Google Scholar]
  • Bodnar L, Catov J, Simham H, et al. 2007. Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 92: 3517–3522. [Google Scholar]
  • Camargo C, Ganmaa D, Frazier L, et al. 2012. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 130: 561–567. [CrossRef] [Google Scholar]
  • Cashman K, Fitzgerald A, Kiely M, et al. 2011. A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br. J. Nutr. 106: 1617–1627. [CrossRef] [PubMed] [Google Scholar]
  • Courbebaisse M, Thervet E, Souberbielle JC, et al. 2009. Effetcs of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 75: 646–651. [CrossRef] [PubMed] [Google Scholar]
  • Dawson-Hughes B, Heaney R, Holick M, et al. 2005. Estimates of optimal vitamin D status. Osteoporos. Int. 16: 713–716. [Google Scholar]
  • Dawson-Hughes B, Mithal A, Bonjour JP, et al. 2010. IOF position statements: vitamin D recommendations for older adults. Osteoporos. Int. 21: 1151–1154. [Google Scholar]
  • Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. 2010. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxy vitamin D, adiposity, and arterial stiffness. J. Clin. Endocrinol. Metab. 95: 4584–4591. [Google Scholar]
  • Eastell R, Arnold A, Brandi ML, et al. 2009. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94: 340–350. [Google Scholar]
  • Feskanich D, Ma J, Fuchs CS, et al. 2004. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol. Biomarkers Prev. 13: 1502–1508. [Google Scholar]
  • Garland CF, Gorham ED, Mohr SB, et al. 2007. Vitamin D and prevention of breast cancer: pooled analysis. J. Steroid Biochem. Mol. Biol. 103: 708–711. [Google Scholar]
  • Grey A, Lucas J, Horne A, et al. 2005. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J. Clin. Endocrinol. Metab. 90: 2122–2126. [Google Scholar]
  • Hathcock J, Shao A, Vieth R, et al. 2007. Risk assessment for vitamin D. Am. J. Clin. Nutr. 85: 6–18. [Google Scholar]
  • Heaney R, Holick M. 2011. Why the IOM recommendations for vitamin D are deficient. J. Bone Miner. Res. 26: 455–457. [Google Scholar]
  • Holick M. 2006. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 116: 2062–2072. [Google Scholar]
  • Holick M. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266–281. [Google Scholar]
  • Holick M, Biancuzzo RM, Chen TC, et al. 2008. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 93: 677–681. [Google Scholar]
  • Holick M, Binkley N, Bischoff-Ferrari H, et al. 2011. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96: 3908. [CrossRef] [Google Scholar]
  • Holick M, Chen T, Lu Z, et al. 2007. Viamin D and skin physiology: a D-lightful story. J. Bone Miner. Res. 2: V28–V33. [Google Scholar]
  • Hollis B. 2005. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135: 317–322. [PubMed] [Google Scholar]
  • Ish-Shalom S, Segal E, Salganik T, et al. 2008. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J. Clin. Endocrinol. Metab. 93: 3430–3435. [Google Scholar]
  • Jackson RD, LaCroix AZ, Gass M, et al. 2006. Calcium plus vitamin d supplementation and the risk of fractures. N. Engl. J. Med. 354: 669–683. [CrossRef] [PubMed] [Google Scholar]
  • Jean G, Souberbielle JC, Chazot C. 2009. Strategy for vitamin D supplementation. Monthly cholecalciferol administration in hemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol. Dial. Transplant. 24: 3799–3805. [Google Scholar]
  • Kampman MT, Steffensen LH, Mellgren SI, et al. 2012. Effect of vitamin D3 supplementation on relapse, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult. Scler. 18: 1144–1151. [CrossRef] [PubMed] [Google Scholar]
  • KDIGO. 2009. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 79: S1–S130. [Google Scholar]
  • Kim MJ, Frankel A, Donaldson M, et al. 2011. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established rennin-angiotensin – aldosterone system inhibition. Kidney Int. 80: 851–860. [CrossRef] [PubMed] [Google Scholar]
  • Lappe JM, Travers-Gustafson D, Davies KM, et al. 2007. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85: 1586–1591. [Google Scholar]
  • Larsen T, Mose F, Bech J, et al. 2012. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25: 1215–1222. [CrossRef] [PubMed] [Google Scholar]
  • Liu PT, Stenger S, Li H, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770–1773. [CrossRef] [PubMed] [Google Scholar]
  • Lowe H, McMahon DJ, Rubin M, et al. 2007. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab. 92: 3001–3005. [Google Scholar]
  • Luxwolda M, Kuiperst R, Kema I, et al. 2012. Traditionnally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L. Br. J. Nutr. 108: 1557–1561. [Google Scholar]
  • Mithal A, Wahl DA, Bonjour JP, et al. 2009. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 11: 1807–1820. [Google Scholar]
  • Mitri J, Dawson-Hughes B, Hu F, et al. 2011. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94: 486–494. [Google Scholar]
  • Murdoch D, Slow S, Chambers S, et al. 2012. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults. JAMA 308: 1333–1339. [CrossRef] [PubMed] [Google Scholar]
  • Nemere I, Schwartz Z, Pedroso H, et al. 1998. Identification of a membrane receptor for 1,25dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J. Bone Miner. Res. 13: 1353–1359. [Google Scholar]
  • Nimer A, Mouch A. 2012. Vitamin D improves viral response in hepatitis C genotype 2–3 naïve patients. World J. Gastroenterol. 18: 800–805. [Google Scholar]
  • Okazaki R, Sugimoto T, Kaji H, et al. 2011. Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 supplementation load in Japanese patients. J. Bone Miner. Metab. 29: 103–110. [Google Scholar]
  • Omenn GS, Goodman GE, Thomquist MD, et al. 1996. Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334: 1150–1155. [Google Scholar]
  • Opdenoordt S. 2010. Cholecalciferol loading dose guideline for vitamin D deficient adults. Eur. J. Endocrinol. 162: 805–810. [CrossRef] [PubMed] [Google Scholar]
  • Perez-Lopez F, Brincat M, Erel T, et al. 2012. EMAS position statement: vitamin D and postmenopausal health. Maturitas 71: 83–88. [CrossRef] [PubMed] [Google Scholar]
  • Pilz S, Iodice S, Zittermann A, et al. 2011. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58: 374–382. [Google Scholar]
  • Pilz S, Tomaschitz A, Ritz E. 2009. Vitamin D status and arterial hypertension: a systematic review. Nat. Rev. Cardiol. 6: 621–630. [Google Scholar]
  • Poel YHM, Hummel P, Lips P, et al. 2012. Vitamin D and gestational diabetes: a systematic review and meta-analysis. Eur. J. Int. Med. 23: 465–469. [Google Scholar]
  • Priemel M, von Domarus C, Klatte TO, et al. 2010. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res. 25: 305–312. [Google Scholar]
  • Ross C, Manson JE, Abrams S, et al. 2011. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96: 53–58. [Google Scholar]
  • Sanders KM, Stuart AL, Williamson EJ, et al. 2010. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303: 1815–1822. [CrossRef] [PubMed] [Google Scholar]
  • Schleithoff SS, Zittermann A, Tenderich G, et al. 2006. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 83: 754–759. [Google Scholar]
  • Schlingmann KP, Pirruccello JP, Do R, et al. 2011. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J Med. 365: 410–421. [Google Scholar]
  • Soilu-Hänninen M, Aivo J, Lindstrom BM, et al. 2012. A randomised double-blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 83: 565–571. [Google Scholar]
  • Tuohimaa P, Tenkanen L, Ahonen M, et al. 2004. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer 108: 104–110. [Google Scholar]
  • Souberbielle JC, Courbebaisse M, Cormier C, et al. 2012. When should we measure vitamin D concentration in clinical practice? Scand. J. Clin. Lab. Invest. Suppl. 243: 129–135. [Google Scholar]
  • Souberbielle JC, Maury E, Friedlander G, Cormier C. 2010. Vitamin D and primary hyperparathyroidism (PHPT). J. Steroid Biochem. Mol. Biol. 121: 199–203. [Google Scholar]
  • Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. 2010. Circulating 25-hydroxyviatmin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am. J. Epidemiol. 172: 81–93. [Google Scholar]
  • Urashima M, Segawa T, Okazaki M, et al. 2010. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 91: 1255–1260. [Google Scholar]
  • Vernay M, Sponga M, Salanave B, et al. 2012. Statut en vitamine D de la population adulte en France: l’étude nationale nutrition santé (ENNS, 2006–2007). BEH, 189–194. [Google Scholar]
  • Vieth R. 2004. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 89: 575–579. [Google Scholar]
  • Witham MD, Nadir MA, Struthers AD. 2009. Effect of vitamin D on blood pressure a systematic review and meta-analysis. J. Hypertens. 27: 1948–1954. [Google Scholar]
  • Zitterman A, Iodice S, Pilz S, et al. 2012. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 95: 91–100. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.